Research ExplorerPublicationsUnplanned Index Limb Revascularization With Rivaroxaban Vers...

Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment

Standard

Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment : Insights From VOYAGER PAD. / Hogan, Shea E; Debus, Eike Sebastian; Nehler, Mark R; Patel, Manesh R; Anand, Sonia S; Muehlhofer, Eva; Haskell, Lloyd P; Berkowitz, Scott D; Bauersachs, Rupert M; Bonaca, Marc P.

In: CIRCULATION, Vol. 149, No. 8, 20.02.2024, p. 635-637.

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Harvard

Hogan, SE, Debus, ES, Nehler, MR, Patel, MR, Anand, SS, Muehlhofer, E, Haskell, LP, Berkowitz, SD, Bauersachs, RM & Bonaca, MP 2024, 'Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD', CIRCULATION, vol. 149, no. 8, pp. 635-637. https://doi.org/10.1161/CIRCULATIONAHA.123.065330

APA

Hogan, S. E., Debus, E. S., Nehler, M. R., Patel, M. R., Anand, S. S., Muehlhofer, E., Haskell, L. P., Berkowitz, S. D., Bauersachs, R. M., & Bonaca, M. P. (2024). Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. CIRCULATION, 149(8), 635-637. https://doi.org/10.1161/CIRCULATIONAHA.123.065330

Vancouver

Hogan SE, Debus ES, Nehler MR, Patel MR, Anand SS, Muehlhofer E et al. Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. CIRCULATION. 2024 Feb 20;149(8):635-637. https://doi.org/10.1161/CIRCULATIONAHA.123.065330

Bibtex

@article{d2b96ac5254e4b7d949d2837bfa0eb83,
title = "Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD",
keywords = "Humans, Chronic Limb-Threatening Ischemia/drug therapy, Endovascular Procedures/adverse effects, Ischemia/diagnostic imaging, Limb Salvage, Lower Extremity/blood supply, Peripheral Arterial Disease/diagnostic imaging, Risk Factors, Rivaroxaban/therapeutic use, Treatment Outcome, Vascular Surgical Procedures, Randomized Controlled Trials as Topic",
author = "Hogan, {Shea E} and Debus, {Eike Sebastian} and Nehler, {Mark R} and Patel, {Manesh R} and Anand, {Sonia S} and Eva Muehlhofer and Haskell, {Lloyd P} and Berkowitz, {Scott D} and Bauersachs, {Rupert M} and Bonaca, {Marc P}",
year = "2024",
month = feb,
day = "20",
doi = "10.1161/CIRCULATIONAHA.123.065330",
language = "English",
volume = "149",
pages = "635--637",
journal = "CIRCULATION",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

RIS

TY - JOUR

T1 - Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment

T2 - Insights From VOYAGER PAD

AU - Hogan, Shea E

AU - Debus, Eike Sebastian

AU - Nehler, Mark R

AU - Patel, Manesh R

AU - Anand, Sonia S

AU - Muehlhofer, Eva

AU - Haskell, Lloyd P

AU - Berkowitz, Scott D

AU - Bauersachs, Rupert M

AU - Bonaca, Marc P

PY - 2024/2/20

Y1 - 2024/2/20

KW - Humans

KW - Chronic Limb-Threatening Ischemia/drug therapy

KW - Endovascular Procedures/adverse effects

KW - Ischemia/diagnostic imaging

KW - Limb Salvage

KW - Lower Extremity/blood supply

KW - Peripheral Arterial Disease/diagnostic imaging

KW - Risk Factors

KW - Rivaroxaban/therapeutic use

KW - Treatment Outcome

KW - Vascular Surgical Procedures

KW - Randomized Controlled Trials as Topic

U2 - 10.1161/CIRCULATIONAHA.123.065330

DO - 10.1161/CIRCULATIONAHA.123.065330

M3 - Letter

C2 - 38377256

VL - 149

SP - 635

EP - 637

JO - CIRCULATION

JF - CIRCULATION

SN - 0009-7322

IS - 8

ER -